Evidence supporting the use of: Astaxanthin
For the health condition: Cataracts

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Astaxanthin is a carotenoid pigment with potent antioxidant properties, commonly found in microalgae, seafood, and certain supplements. Its role in supporting or treating cataracts is primarily based on its antioxidant activity, as oxidative stress is a significant factor in the development and progression of cataracts. Laboratory and animal studies have shown that astaxanthin can help reduce oxidative damage in the eye’s lens, potentially slowing cataract formation. For instance, a few studies in rodents have demonstrated that astaxanthin supplementation can mitigate lens opacification induced by oxidative agents.

However, direct clinical evidence in humans is limited. Most of the available human studies focus on astaxanthin’s general ocular benefits, such as reducing eye fatigue and protecting against retinal damage, rather than specifically preventing or treating cataracts. Some small clinical trials and observational studies suggest that diets rich in carotenoids (including astaxanthin) might be associated with a lower risk of cataract development, but these findings are not specific to astaxanthin and often include other carotenoids like lutein and zeaxanthin.

In summary, while there is some scientific rationale and preclinical evidence supporting the use of astaxanthin for cataract prevention due to its antioxidant effects, robust clinical trials in humans are lacking. Therefore, the evidence base is weak (rated 2/5), and its use for cataracts should be considered experimental and supplementary rather than established therapy.

More about astaxanthin
More about Cataracts